Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 177

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 177
---
 Stock in respect of such event.

If the number of outstanding shares of ParentCo Common Stock is decreased by a consolidation, combination, reverse share split or reclassification of ParentCo Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of shares of ParentCo Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding share of ParentCo Common Stock.

Whenever the number of shares of ParentCo Common Stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares of ParentCo Common Stock purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of shares of ParentCo Common Stock so purchasable immediately thereafter.

In case of any reclassification or reorganization of the outstanding ParentCo Common Stock (other than those described above or that solely affects the par value of such ParentCo Common Stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding ParentCo Common Stock), or in the case of any sale or conveyance to another

<div align='center'>112</div>

#### corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the ParentCo Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of ParentCo Common Stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of ParentCo Common Stock in such a transaction is payable in the form of ParentCo Common Stock in the successor entity that is listed for trading on a national securities exchange or is